Skip to content

Clinical study of Swiss LithoClast? Trilogy for percutaneous nephrolithotomy

Clinical study of Swiss LithoClast? Trilogy for percutaneous nephrolithotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063537
Enrollment
Unknown
Registered
2022-09-10
Start date
2022-09-10
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Calculus

Interventions

Intervention group:Application of Swiss LithoClast? Trilogy for percutaneous nephrolithotomy
Control group:Application of the 5th generation lithotripsy system for percutaneous nephrolithotomy

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Indications for PCNL surgery met; 2. Single stone >= 2.0 cm maximum diameter; 3. Age 18-80 years, regardless of gender; 4. Sign the study informed consent form and agree to participate in all study visits.

Exclusion criteria

Exclusion criteria: 1. Renal transplant patients; 2. Patients with impaired cardiac, hepatic, renal, and respiratory function or other serious diseases; 3. Patients with uncontrolled severe urinary tract infections; 4. Patients with uncorrected coagulation dysfunction; 5. Pregnant or lactating women; 6. Patients with psychiatric disorders; 7. Those who have not signed the informed consent form; (8) Any other patients who are not suitable for entry into the study.

Design outcomes

Primary

MeasureTime frame
Operation time;Lithotripsy time;

Secondary

MeasureTime frame
Device performance;First-stage stone-free rate;Complication rate;

Countries

China

Contacts

Public ContactJianxing Li
ljx1@sina.com+86 13321169366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026